RESULTS OF ORGAN-SPARING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
- Authors: Gumenetskaya Y.1, Popov A.1, Karyakin O.1
-
Affiliations:
- Medical Radiological Research Center
- Issue: Vol 24, No 11 (2013)
- Pages: 51-54
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115817
- ID: 115817
Cite item
Open Access
Access granted
Abstract
The paper presents the results of organ-sparing therapy in 304 patients with muscle-invasive bladder cancer in whom cystectomy was contraindicated.
Full Text
About the authors
Yu. Gumenetskaya
Medical Radiological Research Center
Email: GumenetskayYul@yandex.ru
Candidate of Medical Sciences Obninsk
A. Popov
Medical Radiological Research CenterCandidate of Medical Sciences Obninsk
O. Karyakin
Medical Radiological Research CenterProfessor MD Obninsk
References
- Каприн А.Д., Добровольская Н.Ю., Шестаков А.В. и др. Результаты комплексного и комбинированного лечения инвазивного рака мочевого пузыря // Вестник Российского научного центра рентгенорадиологии Минздрава России. - 2011; 2: 20.
- Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2012 году / М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2013; 232 с.
- Русаков И.Г., Теплов А.А., Перепечин Д.В. и др. Рак мочевого пузыря. Онкология. Нац. рук-во. Под ред. В.И. Чиссова, М.И. Давыдова / М.: ГЭОТАР-Медиа, 2008; с. 777-88.
- Чернышев И.В., Перепечин Д.В., Ульбашев А.М. Химиотерапия в комбинированном лечении местно-распространенного рака мочевого пузыря // Вестник РНЦРР МЗ РФ. -2012; 12: 10.
- Abazeed M., Efstathiou J., Heney N. et al. Bladder preservation strategies for invasive bladder cancer. Comprehensive textbook of genitourinary oncology. Ed. P. Scardino, W. Linehan, M. Zelefsky et al. Philadelphia: Wolters Kluwer, 2011; p. 451-69.
- Balar A., Bajorin D., Milowsky M. Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy // Ther. Adv. Urol. -2011; 3 (3): 107-17.
- Caffo O., Veccia A., Fellin G. et al. Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature // Crit. Rev. Oncol. Hematol. -2013; 86 (2): 176-90.
- Efstathiou J., Bae K., Shipley W. et al. Late pelvis toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06 // J. Clin. Oncol. - 2009; 27 (25): 4051-61.
- Efstathiou J., Spiegel D., Shipley W. et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience // Eur. Urol. - 2012; 61 (4): 705-11.
- Foster W., Lee B., Speight J. Bladder cancer // Handbook of Evidence-Based Radiation Oncology. Second Edition. Ed. E.K. Hansen, M. Roach III / USA: Springer, 2010; p. 419-29.
- Krause F., Walter B., Ott O. et al. 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment // Anticancer Res. - 2011; 31 (3): 985-90.
- Lagrange J., Bascoul-Mollevi C., Geoffrois L. et al. Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015) // Int. J. Radiat. Oncol. Biol. Phys. - 2011; 79 (1): 172-8.
- Rene N., Cury F., Souhami L. Conservative treatment of invasive bladder cancer // Cur. Oncol. - 2009; 16 (4): 36-47.
- Rodel C., Grabenbauer G., Kuhn R. еt al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results [comment] // J. Clin. Oncol. - 2002; 20 (14): 3061-71.
- Zapatero A., Martin de V., Arellano R. et al. Updated results of bladder-sparing trimodality approach for invasive bladder cancer // Urol. Oncol. - 2010; 28 (4): 368-74.
Supplementary files
